Document is current
Any future updates will be listed below
-
Authors
Radomski, Shannon N.
Dunworth, Matthew
West, Junior J.
Greer, Jonathan B.
Johnston, Fabian M.
Ewald, Andrew J.
-
Funding
Funding for this research was provided by:
American College of Surgeons (Resident Research Scholarship)
Commonwealth Foundation for Cancer Research Foundation
National Cancer Institute (5T32CA126607, T32CA153952, U54CA268083)
Black in Cancer/Emerald Foundation
Johns Hopkins SPORE in Gastrointestinal Cancer
Giovanis Institute for Translational Cell Biology
- License Information
-
More Information
Article History
Received: 8 September 2023
Accepted: 16 November 2023
First Online: 4 January 2024
Disclosures
: The authors received support from the NIH / NCI 5T32CA126607 (SNR), NIH/NCI T32CA153952 (MD), NIH/NCI U54CA268083 (AJE), American College of Surgeons Resident Research Scholarship (SNR), the Commonwealth Foundation for Cancer Research (FMJ, AJE), the Johns Hopkins SPORE in Gastrointestinal Cancer at the Sidney Kimmel Comprehensive Cancer Center (SNR, AJE), the Giovanis Institute for Translational Cell Biology (AJE), and the Black in Cancer/Emerald Foundation Postdoctoral Fellowship (JJW). AJE has unlicensed patents related to keratin 14 as a prognostic marker and to antibody strategies for anti-cancer therapeutics. AJE is a consultant for BioNTech. AJE’s spouse is an employee of ImmunoCore.
